Statistics in Biopharmaceutical Research

Papers
(The H4-Index of Statistics in Biopharmaceutical Research is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The Current Landscape in Biostatistics of Real-World Data and Evidence: Causal Inference Frameworks for Study Design and Analysis34
Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group31
Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment25
The Current Landscape in Biostatistics of Real-World Data and Evidence: Clinical Study Design and Analysis21
Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion16
Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event14
Statistical Models for Composite Endpoints of Death and Nonfatal Events: A Review14
Reference-Based Multiple Imputation—What is the Right Variance and How to Estimate It13
Developing a Targeted Learning-Based Statistical Analysis Plan13
Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods12
Using Surrogate Endpoints in Adaptive Designs with Delayed Treatment Effect11
Deep Learning Based Multimodal Progression Modeling for Alzheimer’s Disease11
0.13635611534119